| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/20/2007 | CA2186784C The use of carboxylic acid derivatives as drugs |
| 02/15/2007 | WO2007018319A1 Pyridylphenol compound and use thereof |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007018234A1 Agent for increasing urethral pressure |
| 02/15/2007 | WO2007017094A1 Substituted benzyloxy-phenylmethylcarbamate derivatives |
| 02/15/2007 | WO2007017093A1 Substituted 2-benzyloxy-benzoic acid amide derivatives |
| 02/15/2007 | WO2007017092A1 Substituted 4-benzyloxy-benzoic acid amide derivatives |
| 02/15/2007 | US20070039062 Goodpasture's syndrome model mouse |
| 02/15/2007 | US20070037884 Novel succinate salt of O-desmethyl-venlafaxine |
| 02/15/2007 | US20070037879 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037878 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
| 02/15/2007 | US20070037834 Bicyclic pyrimidine derivatives |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036768 Systems and methods for treating patients with processed lipoaspirate cells |
| 02/15/2007 | DE102005038141A1 Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate Substituted 8- (3-aminopropyl) -1-phenyl-1,3,8-triaza-spiro [4.5] decan-4-one derivatives |
| 02/15/2007 | CA2618446A1 Method of obtaining 3,3-diphenylpropylamines |
| 02/15/2007 | CA2618112A1 Pyridone compound |
| 02/14/2007 | EP1752452A1 Propane-1,3-dione derivative or its salt |
| 02/14/2007 | EP1560828B9 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 02/14/2007 | EP1507514B1 Controlled release compositions of estradiol metabolites |
| 02/14/2007 | EP1444220B1 Compounds and method for the treatment of overactive bladder |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1370552B1 Rho-kinase inhibitors |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases |
| 02/14/2007 | EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911915A Lactam compound and medicinal use thereof |
| 02/14/2007 | CN1911434A Medicinal food for treating kidney-yin deficiency lype infantile enuresis, and its prepn. method |
| 02/14/2007 | CN1911430A Pills for treating infantile enuresis, and its prepn. method |
| 02/14/2007 | CN1911414A Traditional Chinese medicine pills for treating infantile refractory enuresis, and its prepn. method |
| 02/14/2007 | CN1911413A Medicinal food for treating infantile enuresis, and its prepn. method |
| 02/14/2007 | CN1911411A Traditional Chinese medicine prepn. for treating nephrotuberculosis |
| 02/14/2007 | CN1911409A Foot soaking medicine for treating infantile enuresis, and its prepn. method |
| 02/14/2007 | CN1911399A Point application medicine for treating infantile enuresis, and its prepn. method |
| 02/14/2007 | CN1911344A Hip bath medicine for treating chronic prostatitis, and its prepn. method |
| 02/14/2007 | CN1911313A Fuming and washing medicine for treating acute prostatitis, and its prepn. method |
| 02/14/2007 | CN1911310A Umbilicus application medicine for treating infantile enuresis, and its prepn. method |
| 02/14/2007 | CN1911283A Traditional Chinese medicine soft capsule for treating thermal gonorrhea and its prepn. method |
| 02/14/2007 | CN1911267A Medicated food with function of treatment of infantile urocelpsia due to deficiency of kidney-qi, and its prepn. method |
| 02/14/2007 | CN1911256A Medicine for dispelling dampness, removing stone and apocatastasis, and its prepn. method |
| 02/14/2007 | CN1911247A Medicated food for treating infantile uroclepsia due to deficiency of kidney-qi, and its prepn. method |
| 02/14/2007 | CN1911245A Metal compunds, mixed or sulphated, as phosphate binders |
| 02/14/2007 | CN1911221A Use of a hypoglycemic agent for treating impaired glucose metabolism |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |
| 02/14/2007 | CN1299728C Capsules of Tokyo violet, dandelion and flavescent sophora root and their making method |
| 02/14/2007 | CN1299689C Application of alendronate in preparation of drug for inhibitting bone resorption |
| 02/14/2007 | CN1299672C Extracts from sophora,production method and purposes thereof |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176219 Salts of quinuclidine derivative |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
| 02/13/2007 | US7176212 2,4-diamino pyrimidine compounds having anti-cell proliferative activity |
| 02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/13/2007 | US7175997 BMP-11 compositions |
| 02/13/2007 | US7175850 Formulation for topical non-invasive application in vivo |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |
| 02/13/2007 | CA2358840C Methods and kits comprising an estrogen agonist/antagonist for improving vascular health |
| 02/08/2007 | WO2007015585A1 Agent for reduction of oxidized albumin level |
| 02/08/2007 | WO2005070460A3 Combination therapy with 5-ht1a and 5-ht1b receptor antagonists |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032538 Use of compounds |
| 02/08/2007 | US20070032518 Compounds and methods of use |
| 02/08/2007 | US20070032466 Drug containing chymase inhibitor as the active ingredient |
| 02/08/2007 | CA2615209A1 Mc4r-ag0nists for the treatment of urinary tract dysfunction |
| 02/08/2007 | CA2613518A1 Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators |
| 02/07/2007 | EP1749520A1 Water-dispersible encapsulated sterols |
| 02/07/2007 | EP1506211B1 C-aryl glucoside sglt2 inhibitors and method |
| 02/07/2007 | EP1501504B1 1-substituted imidazole derivatives as nos inhibitors |
| 02/07/2007 | EP1261336B1 Il-8 receptor antagonists |
| 02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
| 02/07/2007 | EP1230241B1 Adenosine receptor antagonists and methods of making and using the same |
| 02/07/2007 | EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 02/07/2007 | EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 02/07/2007 | CN1910176A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 02/07/2007 | CN1907472A Chronic prostatitis fuming-washing treating medicine and its preparation |
| 02/07/2007 | CN1907448A Decoction preparation for treating children's nocturnal enuresis caused by lower energizer deficiency and cold and its preparation process |
| 02/07/2007 | CN1907429A Method for preparing and controlling the quality of Chinese medicinal soft capsule |
| 02/07/2007 | CN1907370A Prostatitis fuming-washing treating medicine and its preparation |
| 02/07/2007 | CN1907340A Quality checking and controlling method for renal stone removal preparation |
| 02/07/2007 | CN1907318A Use of ceylon houndstongue and pharmaceutical composition containing same |
| 02/07/2007 | CN1907317A Medicine for treating impotence, spermatorrhea and chronic renal failure, and its preparing process |
| 02/07/2007 | CN1907298A Pill for treating polyuria and its preparing process |
| 02/07/2007 | CN1298862C Glycoprotein and process for producing same |
| 02/07/2007 | CN1298717C Quinuclidine carbamate derivatives and their use as M3 antigonists |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/07/2007 | CN1298384C Medicine for curing lithangiuria |
| 02/07/2007 | CN1298351C Chinese medicine oral preparation for treating urinary system infestation and its preparation method |
| 02/07/2007 | CN1298323C Fused pyrrolocarbazoles against inflammation |
| 02/07/2007 | CN1298319C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 02/07/2007 | CN1298317C Tamsulosin tablets |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173043 Heteroaromate OSC inhibitors |